Single Dose and 34-Day Tolerance Study of INGAP Peptide in Insulin Deficient Patients
Clinical trial NCT00034255 · COMPLETED
Trial details
- NCT number
- NCT00034255
- Sponsor
- GMP Endotherapeutics
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-12-01
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.